Evaxion A (EVAX) Receivables - Other (2019 - 2024)
Evaxion A posted quarterly Receivables - Other of $65000.0 for Q4 2024, down 39.81% year-on-year from $108000.0 in Q1 2024, and down 39.81% on a QoQ basis from $108000.0 in Q4 2023.
Evaxion A (EVAX) has 6 years of Receivables - Other data on file, last reported at $65000.0 in Q4 2024.
- For the quarter ending Q4 2024, Receivables - Other fell 39.81% year-over-year to $65000.0; the trailing twelve-month figure through Dec 2024 stood at $65000.0 (down 39.81% YoY), and the FY2024 full-year result was $65000.0, down 39.81% from the prior year.
- Receivables - Other for Q4 2024 stood at $65000.0, down from $108000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $113000.0 in Q4 2021 and bottomed at $7000.0 in Q4 2020.
- The 5-year median for Receivables - Other is $65000.0 (2024), against an average of $60600.0.
- The widest annual swing landed in 2021, when Receivables - Other soared 1514.29%; it then slumped 91.15% in 2022.
- A 5-year view of Receivables - Other shows it stood at $7000.0 in 2020, then jumped by 1514.29% to $113000.0 in 2021, then plunged by 91.15% to $10000.0 in 2022, then surged by 980.0% to $108000.0 in 2023, then plunged by 39.81% to $65000.0 in 2024.
- The last three Receivables - Other figures came in at $65000.0 (Q4 2024), $108000.0 (Q4 2023), and $10000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2023 | 108,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2021 | 113,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2020 | 7,000.00 |
| Dec 31, 2019 | 32,000.00 |
| Dec 31, 2019 | 32,000.00 |